Annals of Oncology

Annals of Oncology
Title	Annals of Oncology
Discipline	Oncology
Abbreviation	Ann. Oncol.
Publisher	European Society for Medical Oncology
Country	France
Frequency	Monthly
History	1990–present
Impact factor	32.9 (2023)

Annals of Oncology is a peer-reviewed medical journal concentrating on clinical and translational research in oncology. It publishes original articles, reviews, consensus statements, guideline updates, and trial reports that inform practice among clinicians, researchers, and policy makers across institutions such as Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, and Mayo Clinic. The journal serves as an official publication platform for professional bodies including the European Society for Medical Oncology, the European Organisation for Research and Treatment of Cancer, and collaborates with stakeholders from World Health Organization, American Society of Clinical Oncology, and regional cancer centers.

History

Founded in 1990, the journal emerged amid expansion of specialized publications in oncology during a period marked by advances at institutions like MD Anderson Cancer Center, Dana-Farber Cancer Institute, and Johns Hopkins Hospital. Early editorial influence drew contributors from networks including EORTC investigators and trial groups such as National Cancer Institute cooperative groups and Cancer Research UK. Over successive editorial tenures connected to figures associated with European Society for Medical Oncology governance, the journal broadened scope to incorporate translational science from laboratories at Institut Curie, Karolinska Institutet, and German Cancer Research Center while publishing pivotal clinical trial results from consortia involving Groupe d'Oncologie Clinique, SWOG, and NCIC Clinical Trials Group.

Scope and Content

The journal covers multidisciplinary subjects spanning therapeutic modalities developed at centers such as Memorial Sloan Kettering Cancer Center, Royal Marsden Hospital, and Princess Margaret Cancer Centre. Topics include systemic therapy trials influenced by research from National Institutes of Health, biomarker development tied to work at Broad Institute, and surgical oncology reports from teams at Mayo Clinic and Cleveland Clinic. It features guideline and consensus publications involving panels convened by organizations like European Society for Medical Oncology, ESMO Guidelines Committee, and regional bodies including NCCN contributors and representatives from European Commission health initiatives. The journal regularly communicates regulatory-relevant evidence impacting agencies such as European Medicines Agency and Food and Drug Administration through reports of randomized controlled trials, phase I–III studies, real-world evidence linked to registries maintained by SEER Program and methodological advances from groups at Institute for Clinical Evaluative Sciences.

Editorial Leadership and Peer Review

Editorial leadership has included editors affiliated with institutions like Institut Gustave Roussy, University College London, and University of Milan, who coordinated editorial boards comprising experts from Harvard Medical School, University of Oxford, University of Cambridge, Karolinska Institutet, University of Tokyo, and Peking University. The peer-review process engages reviewers drawn from networks at European Society for Medical Oncology, trialists from EORTC, and opinion leaders affiliated with American Association for Cancer Research, ensuring methodological scrutiny of randomized trials, meta-analyses, and translational studies originating from laboratories such as Max Planck Institute and Francis Crick Institute. The journal employs ethical oversight aligned with declarations promoted by bodies like Committee on Publication Ethics and reporting standards endorsed by CONSORT and PRISMA groups.

Abstracting and Indexing

Content is indexed in major bibliographic databases maintained by organizations such as Index Medicus, Scopus, Web of Science, and EMBASE. The journal is listed in citation resources curated by Clarivate Analytics and bibliometric aggregators used by institutions including Times Higher Education and ShanghaiRanking Consultancy. Abstracting services operated by PubMed and database systems at National Library of Medicine facilitate discovery of trial reports, reviews, and guidelines authored by researchers from centers like Johns Hopkins University, Yale School of Medicine, and Imperial College London.

Impact and Reception

The journal's influence is reflected in citation metrics tracked by Clarivate Analytics and adoption of its guideline publications by professional societies including European Society for Medical Oncology and national health services such as NHS England. High-profile trial reports published in the journal have shaped practice at tertiary centers like Memorial Sloan Kettering Cancer Center and influenced regulatory decisions at European Medicines Agency and Food and Drug Administration. Scholarly reception spans endorsements from academic departments at University of California, San Francisco, policy citations by World Health Organization, and critique in venues including The Lancet and BMJ when controversies over trial design or interpretation arise.

Notable Publications and Guidelines

The journal has published landmark randomized trials, subgroup analyses, and consensus guideline series that intersect with recommendations from NCCN, ESMO Guidelines Committee, and guideline adaptation efforts led by ASCO. Notable articles have included pivotal chemotherapy regimen reports impacting practice at MD Anderson Cancer Center, biomarker-driven trial results tied to companion diagnostics developed in collaboration with European Medicines Agency review processes, and multidisciplinary guideline statements used by oncology programs at Royal Marsden Hospital and Princess Margaret Cancer Centre. Consensus papers addressing survivorship and health services research have been cited by national programs such as Cancer Research UK and international task forces convened by World Health Organization.

Category:Oncology journals Category:Monthly journals